Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Range Cancer Therapeutics ETF (NQ:CNCR)

9.020 UNCHANGED
Last Price Updated: 4:15 PM EDT, May 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Range Cancer Therapeutics ETF

News headline image
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint. 
Via Stocktwits
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗
Via Stocktwits
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments ↗
Via Stocktwits
Vor Bio Stock Jumped 19% Today And Retail Investors Are Eyeing A Breakout Rally: Here’s What’s Happening ↗
Via Stocktwits
News headline image
3 Top-Ranked ETFs Under $20 For Your Portfolio ↗
Let us dig into some of the ETFs that are below $20 and have a strong buy rating. These low-priced ETFs could lead to huge gains in the coming months based on market trends. 
Via Talk Markets
Topics ETFs
News headline image
5 Market-Beating Sector ETFs Of Q1 ↗
Here are some of the top performers in the ETF space from different sectors of the market. 
Via Talk Markets
Topics ETFs
News headline image
5 Sector ETFs Beating The Market Halfway Through Q1 ↗
After a weak start to 2024, Wall Street regained momentum, with all three major indices logging their fifth straight week of gains. 
Via Talk Markets
Topics ETFs
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023 ↗
Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend. 
Via Talk Markets
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off. 
Via Talk Markets
News headline image
3 Promising Oncology Stocks To Consider Adding To Your Portfolio ↗
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio. 
Via Talk Markets
News headline image
Best Biotech Stocks & ETFs for mRNA, Gene Editing ↗
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.